Correlation Between Novo Nordisk and MapsPeople

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and MapsPeople at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and MapsPeople into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and MapsPeople AS, you can compare the effects of market volatilities on Novo Nordisk and MapsPeople and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of MapsPeople. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and MapsPeople.

Diversification Opportunities for Novo Nordisk and MapsPeople

0.79
  Correlation Coefficient

Poor diversification

The 3 months correlation between Novo and MapsPeople is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and MapsPeople AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MapsPeople AS and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with MapsPeople. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MapsPeople AS has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and MapsPeople go up and down completely randomly.

Pair Corralation between Novo Nordisk and MapsPeople

Assuming the 90 days trading horizon Novo Nordisk AS is expected to generate 0.52 times more return on investment than MapsPeople. However, Novo Nordisk AS is 1.91 times less risky than MapsPeople. It trades about -0.05 of its potential returns per unit of risk. MapsPeople AS is currently generating about -0.06 per unit of risk. If you would invest  74,340  in Novo Nordisk AS on November 27, 2024 and sell it today you would lose (10,420) from holding Novo Nordisk AS or give up 14.02% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Novo Nordisk AS  vs.  MapsPeople AS

 Performance 
       Timeline  
Novo Nordisk AS 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
MapsPeople AS 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days MapsPeople AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Novo Nordisk and MapsPeople Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novo Nordisk and MapsPeople

The main advantage of trading using opposite Novo Nordisk and MapsPeople positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, MapsPeople can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MapsPeople will offset losses from the drop in MapsPeople's long position.
The idea behind Novo Nordisk AS and MapsPeople AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Commodity Directory
Find actively traded commodities issued by global exchanges
Stocks Directory
Find actively traded stocks across global markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA